Severe shigellosis in childhood.
A prospective study was performed on 20 bacteriologically proven pediatric cases of severe shigellosis admitted to the Department of Pediatrics, Chulalongkorn Hospital during March 1989 to March 1990. Fourteen patients were male and six were female. Shigella B was found in 85% and Shigella D in 15% of cases. The major indications for admission were convulsions and dehydration. Fifteen per cent of cases had underlying malignancies and 42.1% had malnutrition. Most patients had a peak of fever between 39.5 and 40.5 degrees C, serum sodium between 128-144 mEq/l. Mild acidosis was detected in 45% and moderate acidosis in 30% of cases. There were no statistical differences in peak of fever and serum sodium between patients who had convulsion and who did not. Shigellemia was found in one case who also had underlying neuroblastoma. One patient died due to necrotizing enterocolitis, septic shock and renal failure. Most of the organisms found resisted to ampicillin and trimethoprim-sulfamethoxazole (TMP-SMX). However, TMP-SMX was prescribed in most immunocompetent patients and they recovered well. All of three patients with underlying malignancy responded well to ceftriaxone.
Sirivichayakul
C
C
Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Thisyakorn
U
U
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001639:Bicarbonates / Q000097:blood; D002648:Child; D002675:Child, Preschool; D004405:Dysentery, Bacillary / Q000145:classification / Q000188:drug therapy / Q000453:epidemiology* / Q000503:physiopathology; D005260:Female; D006760:Hospitalization; D006801:Humans; D007223:Infant; D008297:Male; D008826:Microbial Sensitivity Tests; D009752:Nutritional Status; D011446:Prospective Studies; D012720:Severity of Illness Index; D012761:Shigella boydii / Q000187:drug effects / Q000302:isolation & purification*; D012762:Shigella dysenteriae / Q000187:drug effects / Q000302:isolation & purification*; D012964:Sodium / Q000097:blood; D013785:Thailand / Q000453:epidemiology; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D001639:Bicarbonates; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D012964:Sodium